Inogen logo
Inogen INGN
$ 5.23 0.18%
report update icon

Quarterly report 2026-Q2
added 08-07-2026

Inogen Balance Sheet 2025-2011 | INGN

Brief overview of Inogen's financial position

Balance sheet changes are traced across five available annual reports between 2021 and 2025.

The asset base decreased -39%, from $489.5 million to $298.6 million. Resources became smaller over the five periods.

Liabilities expanded faster than the asset base, -10.8% versus -39%. Debt-service capacity deserves attention.

Equity funds 64.4% of assets versus 75.6% initially. This creates a conservative balance sheet structure.

Negative net debt of -$86.3 million means cash holdings are larger than debt obligations.

The cash share moved from 48.1% to 34.7%. A higher figure generally provides more room in an adverse scenario.

The accumulated result is -$175.6 million and remains below zero. The number alone does not explain whether losses, dividends or repurchases were the main cause.

Conclusion

Inogen's balance sheet profile is moderate. It should be considered alongside profitability, cash flow and liability maturities.

Annual Balance Sheet Inogen

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-86.3 M -94.4 M -104 M -164 M -209 M -202 M -191 M -197 M -143 M -92.9 M -65.8 M -56.2 M -2.87 M -6.18 M 5.72 M

Long Term Debt

14.3 M 16.6 M 18.3 M 19.8 M 23.3 M 8.08 M - - - - - 315 K 5.39 M 5.06 M 7.1 M

Long Term Debt Current

3.16 M 2.81 M 3.65 M 3.52 M 3.39 M 1.93 M 2.01 M - - - 315 K 299 K - - -

Total Non Current Liabilities

- - - - - - 52.5 M 18.9 M 14.1 M 9.12 M 5.28 M 3.2 M 6.43 M 5.22 M 7.43 M

Total Current Liabilities

63.5 M 76.7 M 72.5 M 65.3 M 61.5 M 56.7 M 50.2 M 46.6 M 33.9 M 22.8 M 22 M 18.7 M - - -

Total Liabilities

106 M 122 M 121 M 108 M 119 M 112 M 103 M 65.5 M 48 M 32 M 27.3 M 21.9 M 26.1 M 19 M 16.6 M

Deferred Revenue

- - - - - - 5.48 M 4.45 M 3.53 M 2.24 M 2.32 M 2.32 M 1.49 M 1.09 M 594 K

Retained Earnings

-176 M -153 M -117 M -14.5 M 69.3 M 75.6 M 81.4 M 60.5 M 8.64 M -12.4 M -45.1 M -56.7 M -62.6 M -81 M -75.8 M

Total Assets

299 M 296 M 326 M 405 M 490 M 462 M 447 M 376 M 275 M 214 M 161 M 140 M 82.4 M 47.6 M 24.1 M

Cash and Cash Equivalents

104 M 114 M 125 M 187 M 236 M 212 M 198 M 197 M 143 M 92.9 M 66.1 M 56.8 M 13.5 M 15.1 M -

Book Value

192 M 174 M 205 M 297 M 370 M 350 M 345 M 310 M 227 M 182 M 134 M 118 M 56.3 M 28.6 M 7.56 M

Total Shareholders Equity

192 M 174 M 205 M 297 M 370 M 350 M 345 M 310 M 227 M 182 M 134 M 118 M -62.4 M -80.8 M -

All numbers in USD currency

Quarterly Balance Sheet Inogen

2026-Q2 2026-Q1 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

12.5 M 13.4 M 15.1 M 16 M 16.3 M 16.6 M 17.4 M 18.1 M 18.6 M 18.3 M 18.9 M 18.3 M 19.2 M 19.8 M 20.7 M - 22.4 M 23.3 M 24.1 M 24.9 M 16.4 M 8.08 M 8.08 M 8.08 M 8.08 M 4.7 M 4.7 M 4.7 M 4.7 M - - - - - - - - - 80 K 159 K 238 K 315 K 80 K 159 K 237 K 315 K 315 K 315 K 315 K 5.39 M 5.39 M 5.39 M 5.39 M - - - - - - - -

Total Liabilities

111 M 103 M 110 M 113 M 110 M 122 M 121 M 121 M 124 M 121 M 113 M 99.6 M 104 M 108 M 119 M - 116 M 119 M 122 M 127 M 120 M 112 M 112 M 112 M 112 M 103 M 103 M 103 M 103 M 65.5 M 65.5 M 65.5 M 65.5 M 48 M 48 M 48 M 48 M 32 M 32 M 32 M 32 M 27.3 M 27.3 M 27.3 M 27.3 M 21.9 M 21.9 M 21.9 M 21.9 M 26.1 M 26.1 M 26.1 M 26.1 M - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 3.15 M 3.53 M 3.65 M 3.58 M 2.76 M 2.24 M 2.24 M 2.24 M 2.24 M 2.32 M 2.32 M 2.32 M 2.32 M 2.32 M 2.32 M 2.32 M 2.32 M 1.49 M 1.49 M 1.49 M 1.49 M - - - - - - - -

Retained Earnings

-188 M -184 M -168 M -163 M -159 M -153 M -143 M -137 M -132 M -117 M -90.4 M -44.7 M -34.8 M -14.5 M 42.1 M - 55.1 M 69.3 M 92.1 M 80 M 74.9 M 75.6 M 75.6 M 75.6 M 75.6 M 81.4 M 81.4 M 81.4 M 81.4 M 60.5 M 60.5 M 60.5 M 60.5 M 8.64 M 8.64 M 8.64 M 8.64 M -12.4 M -12.4 M -12.4 M -12.4 M -45.1 M -45.1 M -45.1 M -45.1 M -56.7 M -56.7 M -56.7 M -56.7 M -62.6 M -62.6 M -62.6 M -62.6 M - - - - - - - -

Total Assets

286 M 286 M 307 M 312 M 308 M 296 M 306 M 309 M 316 M 326 M 344 M 374 M 386 M 405 M 470 M - 475 M 490 M 513 M 498 M 476 M 462 M 462 M 462 M 462 M 447 M 447 M 447 M 447 M 376 M 376 M 376 M 376 M 275 M 275 M 275 M 275 M 214 M 214 M 214 M 214 M 161 M 161 M 161 M 161 M 140 M 140 M 140 M 140 M 82.4 M 82.4 M 82.4 M 82.4 M - - - - - - - -

Cash and Cash Equivalents

87.3 M 93.1 M 106 M 104 M 119 M 114 M 106 M 97.9 M 107 M 125 M 125 M 168 M 164 M 187 M 210 M - 213 M 236 M 242 M 239 M 220 M 212 M 212 M 212 M 212 M 198 M 198 M 198 M 198 M 197 M 197 M 197 M 197 M 143 M 143 M 143 M 143 M 92.9 M 92.9 M 92.9 M 92.9 M 66.1 M 66.1 M 66.1 M 66.1 M 56.8 M 56.8 M 56.8 M 56.8 M 13.5 M 13.5 M 13.5 M 13.5 M 15.1 M 15.1 M - - 3.91 M - - -

Book Value

175 M 183 M 197 M 199 M 198 M 174 M 185 M 188 M 192 M 205 M 231 M 275 M 281 M 297 M 351 M - 358 M 370 M 391 M 371 M 356 M 350 M 350 M 350 M 350 M 345 M 345 M 345 M 345 M 310 M 310 M 310 M 310 M 227 M 227 M 227 M 227 M 182 M 182 M 182 M 182 M 134 M 134 M 134 M 134 M 118 M 118 M 118 M 118 M 56.3 M 56.3 M 56.3 M 56.3 M - - - - - - - -

Total Shareholders Equity

175 M 183 M 197 M 199 M 198 M 174 M 185 M 188 M 192 M 205 M 231 M 275 M 281 M 297 M 351 M 357 M 358 M 370 M 391 M 371 M 356 M 350 M 350 M 350 M 350 M 345 M 345 M 345 M 345 M 310 M 310 M 310 M 310 M 227 M 227 M 227 M 227 M 182 M 182 M 182 M 182 M 134 M 134 M 134 M 134 M 118 M 118 M 118 M 118 M -62.4 M -62.4 M -62.4 M -62.4 M -80.8 M - - - -75.6 M - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Inogen, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
Sintx Technologies Sintx Technologies
SINT
$ 1.74 6.75 % $ 4.83 M usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
$ 27.87 0.16 % $ 24.2 B britainBritain
Stryker Corporation Stryker Corporation
SYK
$ 276.43 0.68 % $ 106 B usaUSA
Tandem Diabetes Care Tandem Diabetes Care
TNDM
$ 19.88 0.4 % $ 1.35 B usaUSA
Sensus Healthcare Sensus Healthcare
SRTS
$ 3.16 0.94 % $ 51.6 M usaUSA
Viemed Healthcare Viemed Healthcare
VMD
$ 8.79 0.78 % $ 342 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
$ 18.49 0.03 % $ 765 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
$ 0.18 6.76 % $ 1.85 M usaUSA
TELA Bio TELA Bio
TELA
$ 0.83 1.05 % $ 39 M usaUSA
Beyond Air Beyond Air
XAIR
$ 3.38 0.93 % $ 28.1 B usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
$ 94.22 0.69 % $ 18.7 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.23 0.71 % $ 600 M israelIsrael
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Nemaura Medical Nemaura Medical
NMRD
- -17.8 % $ 2.74 M britainBritain
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Sientra Sientra
SIEN
- -16.59 % $ 10.3 M usaUSA
Silk Road Medical, Inc Silk Road Medical, Inc
SILK
- - $ 1.07 B usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
ShockWave Medical ShockWave Medical
SWAV
- - $ 12.3 B usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Viveve Medical Viveve Medical
VIVE
- -15.35 % $ 1.71 M usaUSA
ViewRay ViewRay
VRAY
- 1.54 % $ 468 M usaUSA
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 6.81 1.32 % $ 206 M canadaCanada
Tactile Systems Technology Tactile Systems Technology
TCMD
$ 21.73 0.09 % $ 497 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 105.52 0.03 % $ 184 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 1.81 1.09 % $ 1.22 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 6.19 1.09 % $ 837 M usaUSA
Align Technology Align Technology
ALGN
$ 153.49 0.03 % $ 11.1 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.05 0.33 % $ 125 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.26 0.37 % $ 31.9 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 9.19 1.29 % $ 1.38 B usaUSA
AxoGen AxoGen
AXGN
$ 46.69 2.51 % $ 2.15 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 7.52 2.17 % $ 1.86 B usaUSA